116
Views
3
CrossRef citations to date
0
Altmetric
Review

Improving quality and outcomes of coronary artery bypass grafting procedures

&
Pages 617-631 | Received 09 Nov 2015, Accepted 25 Jan 2016, Published online: 19 Feb 2016

References

  • Ferguson TJ. Letter to the Editor: OPCAB vs. Conventional CABG: what we don’t know. J Thorac Cardiovasc Surg. Forthcoming 2015.
  • Favaloro RG. Critical analysis of coronary artery bypass graft surgery: A 30-year journey. J Am Coll Cardiol. 1998;31(#4, Supplement B):1B–63B.
  • Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–228. doi:10.1016/j.jacc.2014.04.008.
  • Giugliano RP, Braunwald E. The year in acute coronary syndrome. J Am Coll Cardiol. 2014;63(3):201–214. doi:10.1016/j.jacc.2013.10.041.
  • Henderson RA, Jarvis C, Clayton T, et al. 10-year mortality outcome of a routine invasive strategy versus a selective invasive strategy in non-ST-segment elevation acute coronary syndrome: the British Heart Foundation RITA-3 randomized trial. J Am Coll Cardiol. 2015;66(5):511–520. doi:10.1016/j.jacc.2015.05.051.
  • Levine GN, O’Gara PT, Bates ER, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2015 doi:10.1161/CIR.0000000000000336. [Epub ahead of print].
  • Moreno PR, Narula J. Thinking outside the lumen: fractional flow reserve versus intravascular imaging for major adverse cardiac event prediction. J Am Coll Cardiol. 2014;63(12):1141–1144. doi:10.1016/j.jacc.2013.07.072.
  • Aarnoudse W, Fearon WF, Manoharan G, et al. Epicardial stenosis severity does not affect minimal microcirculatory resistance. Circulation. 2004;110(15):2137–2142. doi:10.1161/01.CIR.0000143893.18451.0E.
  • Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581–1598. doi:10.1016/j.jacc.2012.08.001.
  • Boden WE, O’Rourke RA, Teo KK, et al. Optimal Medical Therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–1516. doi:10.1056/NEJMoa070829.
  • Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283–1291. doi:10.1161/CIRCULATIONAHA.107.743963.
  • Shaw LJ, Weintraub WS, Maron DJ, et al. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am Heart J. 2012;164(2):243–250. doi:10.1016/j.ahj.2012.05.018.
  • Kern MJ, Lerman A, Bech JW, et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation. 2006;114(12):1321–1341. doi:10.1161/CIRCULATIONAHA.106.177276.
  • Kern MJ, Samady H. Current concepts of integrated coronary physiology in the catheterization laboratory. J Am Coll Cardiol. 2010;55(3):173–185. doi:10.1016/j.jacc.2009.06.062.
  • Pijls NHJ, Van Gelder B, Van Der Voort P, et al. Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995;92(11):3183–3193.
  • Pijls NHJ. Fractional Flow Reserve to Guide Coronary Revascularization. Circ J. 2013;77(3):561–569.
  • Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol. 2010;56(3):177–184. doi:10.1016/j.jacc.2010.04.012.
  • Pijls NH, Sels JW. Functional measurement of coronary stenosis. J Am Coll Cardiol. 2012;59(12):1045–1057. doi:10.1016/j.jacc.2011.09.077.
  • Berry C, Van ‘T Veer M, Witt N, et al. VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice): a multicenter study in consecutive patients. J Am Coll Cardiol. 2013;61(13):1421–1427. doi:10.1016/j.jacc.2012.09.065.
  • Van De Hoef T, Meuwissen M, Sen S, et al. Basal stenosis resistance index and instantaneous wave–free ratio have the same diagnostic performance as fractional flow reserve to detect myocardial ischemia using myocardial perfusion imaging. J Am Coll Cardiol. 2013;61(10):E1756. doi:10.1016/S0735-1097(13)61756-8.
  • Jeremias A, Maehara A, Genereux P, et al. Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study. J Am Coll Cardiol. 2014;63(13):1253–1261. doi:10.1016/j.jacc.2013.09.060.
  • Davies JE, Sen S, Broyd C, et al. Arterial pulse wave dynamics after percutaneous aortic valve replacement: fall in coronary diastolic suction with increasing heart rate as a basis for angina symptoms in aortic stenosis. Circulation. 2011;124(14):1565–1572. doi:10.1161/CIRCULATIONAHA.110.011916.
  • Tonino PAL, De Bruyne B, Pijls NHJ, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213–224. doi:10.1056/NEJMoa0807611.
  • De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367(11):991–1001. doi:10.1056/NEJMoa1205361.
  • Fearon WF, Bornschein B, Tonino PA, et al. Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation. 2010;122(24):2545–2550. doi:10.1161/CIRCULATIONAHA.109.925396.
  • Hlatky MA, De Bruyne B, Pontone G, et al. Quality of life and economic outcomes of assessing fractional flow reserve with computed tomography angiography: the PLATFORM Study. J Am Coll Cardiol. 2015;66:2315–2323. doi:10.1016/j.jacc.2015.09.051.
  • Califf RM. The trouble with ischemia. Am Heart J. 2012;164(2):133–134. doi:10.1016/j.ahj.2012.06.007.
  • Mancini GB, Hartigan PM, Shaw LJ, et al. Predicting outcome in the COURAGE trial (clinical outcomes utilizing revascularization and aggressive drug evaluation): coronary anatomy versus ischemia. JACC Cardiovasc Interv. 2014;7(2):195–201. doi:10.1016/j.jcin.2013.10.017.
  • Stone GW, Hochman JS, Williams DO, et al. Medical therapy with vs. without routine revascularization in patients with stable ischemic heart disease and moderate or severe ischemia: the case for equipoise. J Am Coll Cardiol. 2016;67:81–99. doi:10.1016/j.jacc.2015.09.056.
  • ISCHEMIA. ISCHEMIA trial web site. 2010. Available from: https://ischemiatrial.org.
  • Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294(19):2446–2454. doi:10.1001/jama.294.19.2446.
  • Dagenais GR, Lu J, Faxon DP, et al. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation. 2011;123(14):1492–1500. doi:10.1161/CIRCULATIONAHA.110.978247.
  • Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. New England J Med. 2009;360:961–972. doi:10.1056/NEJMoa0804626.
  • Mohr FW, Morice M-C, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629–638. doi:10.1016/S0140-6736(13)60141-5.
  • Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367:2375–2384.
  • Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012;366(16):1467–1476. doi:10.1056/NEJMoa1110717.
  • Hlatky M. Compelling evidence for coronary-bypass surgery in patients with diabetes. N Engl J Med. 2012;367(25):2437–2438. doi:10.1056/NEJMe1212278.
  • Sipahi I, Akay MH, Dagdelen S, et al. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Intern Med. 2014;174(2):223–230. doi:10.1001/jamainternmed.2013.12844.
  • Raza S, Sabik JF 3rd, Ainkaran P, et al. Coronary artery bypass grafting in diabetics: A growing health care cost crisis. J Thorac Cardiovasc Surg. 2015;150:304-312.e2. doi:10.1016/j.jtcvs.2015.03.041.
  • Raza S, Sabik JF 3rd, Masabni K, et al. Surgical revascularization techniques that minimize surgical risk and maximize late survival after coronary artery bypass grafting in patients with diabetes mellitus. J Thorac Cardiovasc Surg. 2014;148(4):1257–1266 e1259. doi:10.1016/j.jtcvs.2014.06.058.
  • Lopes RD, Mehta RH, Hafley GE, et al. Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation. 2012;125(6):749–756. doi:10.1161/CIRCULATIONAHA.111.040311.
  • Lopes RD, Williams JB, Mehta RH, et al. Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results. Am Heart J. 2012;164(3):379–386 e371. doi:10.1016/j.ahj.2012.05.019.
  • Williams JB, Delong ER, Peterson ED, et al. Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice. Circulation. 2011;123:39–45. doi:10.1161/CIRCULATIONAHA.110.981068.
  • Ferguson TB Jr, Peterson ED, Coombs LP, et al. Use of continuous quality improvement to increase utilization of preoperative beta-blockade and internal mammary artery grafting in patients undergoing coronary artery bypass surgery: a national randomized controlled trial. JAMA. 2003;290:49–56. doi:10.1001/jama.290.1.49.
  • Kocas C, Abaci O, Oktay V, et al. Percutaneous coronary intervention vs. optimal medical therapy–the other side of the coin: medication adherence. J Clin Pharm Ther. 2013;38(6):476–479. doi:10.1111/jcpt.12091.
  • Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125(9):882–887 e881. doi:10.1016/j.amjmed.2011.12.013.
  • Kulik A, Ruel M, Jneid H, et al. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. Circulation. 2015;131(10):927–964. doi:10.1161/CIR.0000000000000182.
  • Iqbal J, Zhang YJ, Holmes DR, et al. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up. Circulation. 2015;131(14):1269–1277. doi:10.1161/CIRCULATIONAHA.114.013042.
  • Schwann TA, Tranbaugh RF, Habib RH. The case for multiple arterial coronary artery bypass graft: No longer a leap of faith. J Thorac Cardiovasc Surg. 2015;149(5):1461–1463. doi:10.1016/j.jtcvs.2014.09.122.
  • Puskas JD, Lazar HL, Mack MJ, et al. State-of-the-art coronary artery bypass graft. Semin Thorac Cardiovasc Surg. 2014;26(1):76–94. doi:10.1053/j.semtcvs.2014.03.002.
  • Taggart DP, Ben Gal Y, Lees B, et al. A randomized trial of external stenting for saphenous vein grafts in coronary artery bypass grafting. Ann Thorac Surg. 2015;99(6):2039–2045. doi:10.1016/j.athoracsur.2015.01.060.
  • Meirson T, Orion E, Di Mario C, et al. Flow patterns in externally stented saphenous vein grafts and development of intimal hyperplasia. J Thorac Cardiovasc Surg. 2015;150(4):871–879. doi:10.1016/j.jtcvs.2015.04.061.
  • Toeg HD, Boodhwani M. External stenting of vein grafts: Primum non nocere. J Thorac Cardiovasc Surg. 2015;150(4):774–775. doi:10.1016/j.jtcvs.2015.06.056.
  • Lamy A, Devereaux PJ, Prabhakaran D, et al. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med. 2012;366:1489–1497. doi:10.1056/NEJMoa1200388.
  • Lamy A, Devereaux PJ, Prabhakaran D, et al. Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med. 2013;368(13):1179–1188. doi:10.1056/NEJMoa1301228.
  • Diegeler A, Börgermann J, Kappert U, et al. Off-pump versus on-pump coronary-artery bypass grafting in elderly patients. N Engl J Med. 2013;368(13):1189–1198. doi:10.1056/NEJMoa1211666.
  • Houlind K, Fenger-Gron M, Holme SJ, et al. Graft patency after off-pump coronary artery bypass surgery is inferior even with identical heparinization protocols: results from the Danish On-pump Versus Off-pump Randomization Study (DOORS). J Thorac Cardiovasc Surg. 2014;148(5):1812–1819. doi:10.1016/j.jtcvs.2014.02.024.
  • Møller CH, Perko MJ, Lund JT, et al. No major differences in 30-day outcomes in high-risk patients randomized to off-pump versus on-pump coronary bypass surgery: the best bypass surgery trial. Circulation. 2010;121(4):498–504. doi:10.1161/CIRCULATIONAHA.109.880443.
  • Nakano J, Okabayashi H, Noma H, et al. The impact of incomplete revascularization and angiographic patency on midterm results after off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2014;147(4):1225–1232. doi:10.1016/j.jtcvs.2013.03.026.
  • Robertson MW, Buth KJ, Stewart KM, et al. Complete revascularization is compromised in off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2013;145(4):992–998. doi:10.1016/j.jtcvs.2012.03.052.
  • Barili F, Rosato S, D’Errigo P, et al. Impact of off-pump coronary artery bypass grafting on long-term percutaneous coronary interventions. J Thorac Cardiovasc Surg. 2015;150(4):902–909 e906. doi:10.1016/j.jtcvs.2015.07.018.
  • Lee R. The emperor’s new clothes. J Thorac Cardiovasc Surg. 2015;150(4):909–910. doi:10.1016/j.jtcvs.2015.07.092.
  • Grau JB, Johnson CK, Kuschner CE, et al. Impact of pump status and conduit choice in coronary artery bypass: A 15-year follow-up study in 1412 propensity-matched patients. J Thorac Cardiovasc Surg. 2015;149(4):1027–1033 e1022. doi:10.1016/j.jtcvs.2014.12.031.
  • Kurlansky PA, Traad EA, Dorman MJ, et al. Bilateral internal mammary artery grafting reverses the negative influence of gender on outcomes of coronary artery bypass grafting surgery. Eur J Cardiothorac Surg. 2013;44(1):54–63. doi:10.1093/ejcts/ezs683.
  • Grau JB, Ferrari G, Mak AW, et al. Propensity matched analysis of bilateral internal mammary artery versus single left internal mammary artery grafting at 17-year follow-up: validation of a contemporary surgical experience. Eur J Cardiothorac Surg. 2012;41(4):770–775. doi:10.1093/ejcts/ezr213. discussion 776.
  • Dhurandhar V, Saxena A, Parikh R, et al. Outcomes of on-pump versus off-pump coronary artery bypass graft surgery in the high risk (AusSCORE > 5). Heart Lung Circ. 2015;24(12):1216–1224.
  • Ferguson TB Jr, Chen C, Babb JD, et al. Fractional flow reserve-guided coronary artery bypass grafting: Can intraoperative physiologic imaging guide decision making? J Thorac Cardiovasc Surg. 2013;146(4):824–835 e821. doi:10.1016/j.jtcvs.2013.06.026.
  • Hu S, Yuan X. Reflections inspired by the debate on conventional and off-pump coronary artery bypass graft. J Thorac Cardiovasc Surg. 2015;150(3):734–735. doi:10.1016/j.jtcvs.2015.05.025.
  • Benedetto U, Raja SG, Soliman RF, et al. Minimally invasive direct coronary artery bypass improves late survival compared with drug-eluting stents in isolated proximal left anterior descending artery disease: A 10-year follow-up, single-center, propensity score analysis. J Thorac Cardiovasc Surg. 2014;148(4):1316–1322. doi:10.1016/j.jtcvs.2013.12.062.
  • Institute of Medicine Committee on the Learning Health Care System in America. Best care at lower cost: the path to continuously learning health care in America. Washington (DC): National Academies Press; 2013.
  • Davierwala P, Mohr FW. Five years after the SYNTAX trial: what have we learnt? Eur J Cardiothorac Surg. 2013;44(1):1–3. doi:10.1093/ejcts/ezt267.
  • Brizzio ME, Zapolanski A, Shaw RE, et al. Stroke-related mortality in coronary surgery is reduced by the off-pump approach. Ann Thorac Surg. 2010;89(1):19–23. doi:10.1016/j.athoracsur.2009.07.076.
  • Mack M. Can we make stroke during cardiac surgery a never event? J Thorac Cardiovasc Surg. 2015;149(4):965–967. doi:10.1016/j.jtcvs.2014.12.072.
  • Moss E, Puskas JD, Thourani VH, et al. Avoiding aortic clamping during coronary artery bypass grafting reduces postoperative stroke. J Thorac Cardiovasc Surg. 2014;149(1):175–180.
  • Emmert MY, Seifert B, Wilhelm M, et al. Aortic no-touch technique makes the difference in off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2011;142(6):1499–1506. doi:10.1016/j.jtcvs.2011.04.031.
  • Puskas JD, Yanagawa B, Taggart DP. Off-pump, multiple arterial grafting with minimal aortic manipulation: is it for everyone? J Thorac Cardiovasc Surg. 2015;151(1):4–6. doi:10.1016/j.jtcvs.2015.09.116.
  • Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014;63(8):747–762. doi:10.1016/j.jacc.2013.09.070.
  • LaPar DJ, Filardo G, Crosby IK, et al. The challenge of achieving 1% operative mortality for coronary artery bypass grafting: A multi-institution Society of Thoracic Surgeons Database analysis. J Thorac Cardiovasc Surg. 2014;148(6):2686–2696. doi:10.1016/j.jtcvs.2014.06.086.
  • Raza S, Blackstone EH, Sabik JF 3rd. The diabetes epidemic and its effect on cardiac surgery practice. J Thorac Cardiovasc Surg. 2015;150(4):783–784. doi:10.1016/j.jtcvs.2015.07.037.
  • Sako EY, Brooks MM, Hardison RM, et al. Coronary artery bypass in patients with type 2 diabetes: experience from the bypass angioplasty revascularization investigation 2 diabetes trial. J Thorac Cardiovasc Surg. 2014;148(4):1268–1272. doi:10.1016/j.jtcvs.2013.11.038.
  • Reddan DN. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol. 2003;14(9):2373–2380.
  • Bureau of health informatics office of quality and patient safety New York Department of Health, SPARCS Operations Guide Ver 1.1 [Internet]. 2014 [cited 2016 Feb 5]. Available from: http://www.health.ny.gov/statistics/sparcs/training/docs/sparcs_operations_guide.pdf
  • Windecker S, Kolh P, Alfonso F, et al. 2014 EST/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2015;10(9):1024–1094. doi:10.4244/EIJY14M09_01.
  • Sunagawa G, Komiya T, Tamura N, et al. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. Ann Thorac Surg. 2010;89(6):1896–1900. discussion 1900. doi:10.1016/j.athoracsur.2010.02.080.
  • Chang TI, Leong TK, Boothroyd DB, et al. Acute kidney injury after CABG versus PCI: an observational study using 2 cohorts. J Am Coll Cardiol. 2014;64(10):985–994. doi:10.1016/j.jacc.2014.04.077.
  • Bangalore S, Guo Y, Samadashvili Z, et al. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med. 2015;372(13):1213–1222. doi:10.1056/NEJMoa1412168.
  • Yanagawa B, Algarni KD, Singh SK, et al. Clinical, biochemical, and genetic predictors of coronary artery bypass graft failure. J Thorac Cardiovasc Surg. 2014;148(2):515–520 e512. doi:10.1016/j.jtcvs.2013.10.011.
  • Deb S, Cohen EA, Singh SK, et al. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol. 2012;60(1):28–35. doi:10.1016/j.jacc.2012.03.037.
  • Cho KR, Kim JS, Choi JS, et al. Serial angiographic follow-up of grafts one year and five years after coronary artery bypass surgery. Eur J Cardiothorac Surg. 2006;29(4):511–516. doi:10.1016/j.ejcts.2005.12.026.
  • Culler SD, Kugelmass AD, Brown PP, et al. Trends in coronary revascularization procedures among Medicare beneficiaries between 2008 and 2012. Circulation. 2015;131(4):362–370. discussion 370. doi:10.1161/CIRCULATIONAHA.114.012485
  • Hess CN, Lopes RD, Gibson CM, et al. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation. 2014;130:1445–1451. doi:10.1161/CIRCULATIONAHA.113.008193.
  • ASA M. Medistim ASA first quarter 2013 [Internet]. 2013 [cited 2016 Feb 5]. Available from: http://www.medistim.com/wp-content/uploads/2013/08/presentasjon-2-kvartal-2013.pdf
  • Kieser TM, Rose S, Kowalewski R, et al. Transit-time flow predicts outcomes in coronary artery bypass graft patients: a series of 1000 consecutive arterial grafts. Eur J Cardiothorac Surg. 2010;38(2):155–162. doi:10.1016/j.ejcts.2010.01.026.
  • Balacumaraswami L, Abu-Omar Y, Choudhary B, et al. A comparison of transit-time flowmetry and intraoperative fluorescence imaging for assessing coronary artery bypass graft patency. J Thorac Cardiovasc Surg. 2005;130(2):315–320. doi:10.1016/j.jtcvs.2004.11.033.
  • Buch AN, Chen C Jr, Ferguson TB. Revascularization for stable ischemic heart disease: are there new parallels between percutaneous coronary intervention and coronary artery bypass grafting? Interv Cardiol. 2015;7(2):149–167. doi:10.2217/ica.14.76.
  • Desai ND, Miwa S, Kodama D, et al. A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts. J Thorac Cardiovasc Surg. 2006;132(3):585–594. doi:10.1016/j.jtcvs.2005.09.061.
  • Zhao DX, Leacche M, Balaguer JM, et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol. 2009;53(3):232–241. doi:10.1016/j.jacc.2008.10.011.
  • Meier P, Hemingway H, Lansky AJ, et al. The impact of the coronary collateral circulation on mortality: a meta-analysis. Eur Heart J. 2012;33:614–621. doi:10.1093/eurheartj/ehr308.
  • Botman CJ, Schonberger J, Koolen S, et al. Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. Ann Thorac Surg. 2007;83(6):2093–2097. doi:10.1016/j.athoracsur.2007.01.027.
  • Detter C, Wipper S, Russ D, et al. Fluorescent cardiac imaging: a novel intraoperative method for quantitative assessment of myocardial perfusion during graded coronary artery stenosis. Circulation. 2007;116(9):1007–1014. doi:10.1161/CIRCULATIONAHA.106.655936.
  • Ferguson TB, Chen C. Does the concept of functional stenosis exist in surgical revascularization with CABG? J Am Coll Cardiol. 2012;59(13):E1453. doi:10.1016/S0735-1097(12)61454-5.
  • Jelenc M, Jelenc B, Klokočovnik T, et al. Understanding coronary artery bypass transit time flow curves: role of bypass graft compliance. Interact Cardiovasc Thorac Surg. 2014;18(2):164–168. doi:10.1093/icvts/ivt457.
  • Walker PF, Daniel WT, Moss E, et al. The accuracy of transit time flow measurement in predicting graft patency after coronary artery bypass grafting. Innovations. 2013;8:416–419. doi:10.1097/IMI.0000000000000021.
  • Shahian DM, O’Brien SM, Sheng S, et al. Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation. 2012;125(12):1491–1500. doi:10.1161/CIRCULATIONAHA.111.066902.
  • Head SJ, Mack MJ, Holmes DR Jr, et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur J Cardiothorac Surg. 2012;41(3):535–541. doi:10.1093/ejcts/ezr105.
  • Meier P, Gloekler S, Zbinden R, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation. 2007;116(9):975–983. doi:10.1161/CIRCULATIONAHA.107.703959.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.